These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 22986401)
1. ACP Journal Club. Short-term was less effective than long-term flecainide for preventing recurrent AF after cardioversion. Wyse DG Ann Intern Med; 2012 Sep; 157(6):JC3-9. PubMed ID: 22986401 [No Abstract] [Full Text] [Related]
2. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial. Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956 [TBL] [Abstract][Full Text] [Related]
3. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat. Eijsbouts S; Ausma J; Blaauw Y; Schotten U; Duytschaever M; Allessie MA J Cardiovasc Electrophysiol; 2006 Jun; 17(6):648-54. PubMed ID: 16836716 [TBL] [Abstract][Full Text] [Related]
4. ACP journal club. Rivaroxaban was noninferior to enoxaparin for preventing short-term recurrent VTE and superior to placebo in continued treatment. Douketis J Ann Intern Med; 2011 May; 154(10):JC5-06, JC5-07. PubMed ID: 21576524 [No Abstract] [Full Text] [Related]
5. Can short-term verapamil therapy reduce the recurrence of atrial fibrillation after successful low energy intracardiac cardioversion? Zardo F; Antonini-Canterin F; Brieda M; Hrovatin E; Pavan D; Burelli C; Cervesato E; Nicolosi GL Ital Heart J; 2001 Jul; 2(7):513-8. PubMed ID: 11501960 [TBL] [Abstract][Full Text] [Related]
6. ACP Journal Club. Lenient rate control is as effective as strict rate control for preventing cardiovascular events in AF. Nieuwlaat R; Connolly SJ Ann Intern Med; 2010 Aug; 153(4):JC2-4. PubMed ID: 20713783 [No Abstract] [Full Text] [Related]
7. Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs. Schilling RJ Heart; 2010 Mar; 96(5):333-8. PubMed ID: 19910286 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of pharmacologic cardioversion of atrial fibrillation by Class I drugs. Allessie MA; Wijffels MC; Dorland R J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S69-77. PubMed ID: 9727679 [TBL] [Abstract][Full Text] [Related]
9. [Electrophysiological effects of flecainide on stimulus-inducible ventricular tachycardia]. Breithardt G; Borggrefe M; Yeh HL; Seipel L Z Kardiol; 1982 Apr; 71(4):278-83. PubMed ID: 7090468 [TBL] [Abstract][Full Text] [Related]
10. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088 [TBL] [Abstract][Full Text] [Related]
12. ACP Journal Club. Corticosteroid injections improved short-term but not long-term recovery and pain in the greater trochanteric pain syndrome. Denman M Ann Intern Med; 2011 Oct; 155(8):JC4-9. PubMed ID: 22007068 [No Abstract] [Full Text] [Related]
13. ACP Journal Club is dead...long live ACP Journal Club. Haynes RB ACP J Club; 2008; 148(2):A8. PubMed ID: 18311857 [No Abstract] [Full Text] [Related]
14. Impact of serum flecainide level on control of atrial fibrillation in a case treated with cardiac resynchronization therapy. Doki K; Homma M; Kuga K; Kawano S; Aonuma K; Yamaguchi I; Kohda Y J Clin Pharm Ther; 2007 Aug; 32(4):409-11. PubMed ID: 17635343 [TBL] [Abstract][Full Text] [Related]
15. Cardioversion of acute atrial fibrillation in the short observation unit: comparison of a protocol focused on electrical cardioversion with simple antiarrhythmic treatment. Cristoni L; Tampieri A; Mucci F; Iannone P; Venturi A; Cavazza M; Lenzi T Emerg Med J; 2011 Nov; 28(11):932-7. PubMed ID: 20947916 [TBL] [Abstract][Full Text] [Related]
16. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion. Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472 [TBL] [Abstract][Full Text] [Related]
17. Impact of matrix metalloproteinase-2 levels on long-term outcome following pharmacological or electrical cardioversion in patients with atrial fibrillation. Kato K; Fujimaki T; Yoshida T; Oguri M; Yajima K; Hibino T; Murohara T Europace; 2009 Mar; 11(3):332-7. PubMed ID: 19147485 [TBL] [Abstract][Full Text] [Related]